Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events

NCT01968967 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2139
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer